Table 2 Univariate analyses to identify the risk factors for thrombosis in the LSPV stump
Variable | Patients with thrombosis (n = 5) | Patients without thrombosis (n = 95) | P value |
|---|---|---|---|
Age, years, mean value (range) | 69 (63–75) | 67 (39–80) | 0.557 |
Sex, n (%) | |||
Male /female | 4 (80)/(20) | 54 (57)/41 (43) | 0.329 |
Smoking index, mean value (range) | 853 (0–1290) | 574 (0–2250) | 0.313 |
CEA, ng/mL, mean value (range) | 3.9 (2.1–7.4) | 7.3 (0.5–152) | 0.658 |
Comorbidity, n (%) | |||
Hypertension | 1 (20) | 38 (40) | 0.389 |
Diabetes mellitus | 1 (20) | 19 (20) | 1.000 |
Hyperlipidemia | 0 (0) | 9 (10) | 0.999 |
Preoperative chemotherapy, n (%) | 0 (0) | 3 (3) | 0.999 |
Preoperative chest radiotherapy, n (%) | 0 (0) | 0 (0) | N/A |
VATS, n (%) | 4 (80) | 69 (73) | 0.719 |
PVS treatment, n (%) | |||
Ligation/stapler | 0 (0)/5 (100) | 7 (7)/88 (93) | 0.999 |
Together /respective | 3 (60)/2 (40) | 80 (84)/15 (16) | 0.184 |
Operative time, minutes, median value (range) | 290 (228–399) | 249 (157–530) | 0.175 |
Blood loss, ml, mean value (range) | 255 (58–590) | 223 (20–2900) | 0.858 |
Atrial fibrillation, n (%) | 2 (40) | 9 (10) | 0.058 |
Chemotherapy, n (%) | 1 (20) | 29 (31) | 0.621 |
Chest radiotherapy, n (%) | 3 (60) | 14 (15) | 0.024 |